05 Dec First COVID-19 Drug Research in Space
The 21st SpaceX cargo mission carried the Kirara#2 service mission, and with it a “first of its kind” experiment related to COVID-19, to our ICE Cubes lab in space. Hungarian companies InnoStudio Inc. and CycloLab Cyclodextrin R&D Laboratory Ltd. will incubate the remdesivir-based medicament Veklury® for treatment of COVID-19 using the protein crystalisation service “Kirara” provided by Japan Manned Space Systems Corporation (JAMSS).
The study targets to combine advantages of the microgravity environment with advanced drug research to improve understanding of the complex formulation processes. As such it is also a key initiative for the pharma industry to widen their development opportunities via space research. This first space experiment related to COVID-19 drug discovery research will be accommodated in the ICE Cubes Facility on-board the International Space Station.
Read more here